%0 Journal Article
%A Zitricky, Frantisek
%A Försti, Asta
%A Hemminki, Akseli
%A Hemminki, Otto
%A Hemminki, Kari
%T Conditional Survival in Prostate Cancer in the Nordic Countries Elucidates the Timing of Improvements.
%J Cancers
%V 15
%N 16
%@ 2072-6694
%C Basel
%I MDPI
%M DKFZ-2023-01736
%P 4132
%D 2023
%Z #LA:C020#
%X The incidence of prostate cancer (PC) increased vastly as a result of prostate-specific antigen (PSA) testing. Survival in PC improved in the PSA-testing era, but changes in clinical presentation have hampered the interpretation of the underlying causes.We analyzed survival trends in PC using data from the NORDCAN database for Denmark (DK), Finland (FI), Norway (NO) and Sweden (SE) by analyzing 1-, 5- and 10-year relative survival and conditional relative survival over the course of 50 years (1971-2020).In the pre-PSA era, survival improved in FI and SE and improved marginally in NO but not in DK. PSA testing began toward the end of the 1980s; 5-year survival increased by approximately 30
%K PSA screening (Other)
%K periodic survival (Other)
%K prognosis (Other)
%K treatment (Other)
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:37627160
%2 pmc:PMC10453103
%R 10.3390/cancers15164132
%U https://inrepo02.dkfz.de/record/282352